Steve Aselage - Director at Acer Therapeutics Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
ACER
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Steve Aselage since 13 Sep 2025

Reported holdings for Steve Aselage in Acer Therapeutics Inc.

Form 4 holding Director

Acer Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
20,000
Estimated value
Report date
14 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Acer Therapeutics Inc.

Security class
Common Stock, $0.0001 par value per share
Shares / value
0
Estimated value
Report date
17 Nov 2023
Price
Ownership
Direct

Transaction history for Steve Aselage in Acer Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .